Skip to main content
Premium Trial:

Request an Annual Quote

Valentis Posts Flat Revenue, Loss in Q4; Shuttered London Facility Kept Costs Down

NEW YORK, Feb. 12 - Valentis on Tuesday reported that shuttering its London operations helped it to post flat net losses atop stagnant revenue for the fourth quarter 2001.


Total revenue for the period ended Dec. 31 was $1.3 million, compared with $1.2 million one year ago. R&D spending, meanwhile, which fell to $6.7 million from $7.7 million in the year-ago period, helped keep overall expenses down to $10.2 million from $11.2 million year over year.


As a result, net loss in the quarter remained flat at $9.9 million, or $.33 per share, compared with $9.9 million, or $.34 per share last year.


"We announced our corporate restructuring in January to focus our clinical efforts on the Del-1 Genemedicine product and reduce the level of our pre-clinical efforts," Benjamin F. McGraw, Valentis' president and CEO, said in a statement. "These changes will result in a lower cash burn rate for the company and will keep our financial resources ... in line with our operational goals.


"We are focusing on the Del-1 angiogenesis product in the clinic because we believe it will allow us to achieve clinical validation of our Genemedicine platform," McGraw added. To validate the company's GeneSwitch platform, he said, Valentis will develop the Epo GeneSwitch product.

The company also said that its OptiPEG technology is "the basis or our third product platform, and we are making good progress in moving those technologies through development."



The Scan

Study Tracks Responses in Patients Pursuing Polygenic Risk Score Profiling

Using interviews, researchers in the European Journal of Human Genetics qualitatively assess individuals' motivations for, and experiences with, direct-to-consumer polygenic risk score testing.

EHR Quality Improvement Study Detects Demographic-Related Deficiencies in Cancer Family History Data

In a retrospective analysis in JAMA Network Open, researchers find that sex, ethnicity, language, and other features coincide with the quality of cancer family history information in a patient's record.

Inflammatory Bowel Disease Linked to Gut Microbiome Community Structure Gradient in Meta-Analysis

Bringing together data from prior studies, researchers in Genome Biology track down microbial taxa and a population structure gradient with ties to ulcerative colitis or Crohn's disease.

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.